Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
89 participants
OBSERVATIONAL
2018-04-16
2018-10-12
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Virtual Reality Pain Study
NCT05293275
Use of Virtual Reality in Pain Management in Hospitalized Patients
NCT05545033
Change in Pain With Virtual Reality-augmented Remote Rehabilitative Care
NCT05253157
A Study to Assess Virtual Reality by Healthcare Providers: A Pilot Study
NCT04622527
Virtual Reality Analgesia In Trauma Rehab
NCT03894592
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Virtual Reality Exposure
Exposure to Virtual Reality program for up to 30 minutes
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Inpatients on a general care unit
* Current or recorded moderate to severe pain in past 24 hours
Exclusion Criteria
* Admitted for treatment of psychiatric or mental health disorder
* History of seizure or stroke
* Legally blind or deaf
* Moderate or severe cognitive impairment
* Head wounds or bandages
* On isolation precautions.
20 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Massachusetts General Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Paul Arnstein
Clinical Nurse Specialist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Paul M Arnstein, PhD
Role: PRINCIPAL_INVESTIGATOR
Massachusetts General Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Massachusetts General Hospital
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2017P002788
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.